11th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
11th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
March 7, 2015
InterContinental Miami
100 Chopin Plaza
Miami, FL 33131
Phone: (305) 577-1000
Overview
The
11th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a one-day educational and scientific meeting that will focus on key clinical topics in the management of melanoma and other cutaneous malignancies, including evolving standards of care and current guidelines for chemotherapeutics, targeted agents, local and regional therapies, and immunotherapies, as well as the proper combinations and sequences of the most promising novel agents currently undergoing clinical trial evaluation. This highly practical and interactive forum will provide a unique opportunity for oncologists and other health care professionals to learn from and interact with leading national faculty in order to increase clinical knowledge, apply new data to practice, and ultimately improve patient outcomes.
Target Audience
This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate.
Learning Objectives
At the conclusion of this activity, participants should be better prepared to:
-
Choose treatment based on patient characteristics, such as age and performance status
-
Assess the roles of regional therapies, targeted therapies, and immunotherapies in the treatment of patients
-
Review strategies for mitigating and managing adverse events related to therapy
-
Describe current and emerging strategies for individualizing therapy
-
Evaluate emerging clinical data regarding new regional therapies, targeted therapies, and immunotherapies in treating melanoma and other cutaneous malignancies
Program Co-Chairs
Jeffrey S. Weber, MD, PhD
Senior Member and Director
Donald A. Adam Comprehensive Melanoma Research Center
Moffitt Cancer Center
Tampa, FL
Omid Hamid, MD
Chief, Translational Research and Immunotherapy
Director, Melanoma Therapeutics
The Angeles Clinic and Research Institute
Keynote Speaker
Sam Donaldson